What Does Food and Drug Administration Regulation Mean for Consumers and Businesses?

Prescription drugs and new molecular entities must undergo preclinical testing, an Investigational New Drug (IND) application, and multi-phase clinical trials before submission of a New Drug Application (NDA) or Biologics License Application (BLA), a process typically spanning ten or more years. Over-the-counter drugs follow a less rigorous pathway, often relying on a monograph system in which the FDA establishes categories of active ingredients and formulations deemed safe and effective without individual company approval. Dietary supplements, by contrast, do not require FDA pre-market approval; manufacturers bear responsibility for safety and efficacy claims, and the FDA may only intervene post-market if evidence of harm emerges or if a product is adulterated or misbranded. Medical devices are classified into three risk tiers, with high-risk devices (Class III) requiring premarket approval, moderate-risk devices (Class II) requiring a 510(k) substantial equivalence submission, and low-risk devices (Class I) subject only to general controls and registration.

FDA inspection records, warning letters, recall notices, and adverse event data (collected in the FDA's database systems such as FAERS for drugs or MAUDE for devices) become critical evidence in product liability litigation because they demonstrate the agency's knowledge of a safety hazard, the manufacturer's failure to disclose known risks, or the inadequacy of warnings. A consumer alleging injury from a defective drug or device may obtain FDA records through Freedom of Information Act (FOIA) requests, discovery in civil litigation, or public databases, and these records often establish a pattern of complaints or regulatory violations that strengthen a negligence or strict liability claim. Conversely, evidence that a product met FDA requirements at the time of manufacture does not guarantee a manufacturer's defense; courts apply state-law standards of care and may find a product defective even if FDA-approved, particularly if new scientific evidence or post-market data reveals previously unknown risks.

The FDA enforces the Food Safety Modernization Act (FSMA) and prior hazard analysis standards, which require importers of food and seafood to verify that foreign suppliers maintain safety controls equivalent to U.S. .tandards and to maintain detailed records of the supply chain. Seafood import regulation imposes additional requirements, including species verification, pathogen testing, and traceability documentation, because seafood carries heightened risk of contamination from environmental toxins and pathogens. An importer who fails to conduct adequate supplier verification or maintain required documentation faces FDA enforcement action, product detention at ports of entry, and potential civil or criminal penalties, even if the importer did not manufacture or directly control the product's safety.

Your first priority is to cease use of the product and preserve it in its original condition, including packaging, lot numbers, and any remaining contents, as this physical evidence will be critical in establishing the product's identity and condition at the time of injury. Report the adverse event to the FDA through its MedWatch program (for drugs and devices) or SaferProducts portal (for consumer products), as well as to your healthcare provider, whose medical records will document the nature and timeline of your injury and any causal connection to product exposure. Gather and organize all documentation related to the purchase, use, and injury: receipts, photographs, medical bills and records, communications with the manufacturer or retailer, and any written complaints you made; this organized record will assist your attorney in evaluating the strength of a potential claim and in preparing discovery requests to the manufacturer.